Cited by 135Dupuytren's Contracture and TreatmentsHippo pathway signaling and YAP/TAZTGF-β signaling in diseases

YAP1 Is a Driver of Myofibroblast Differentiation in Normal and Diseased Fibroblasts

Open access
Piersma, Bram, de Rond, Saskia, Werker, Paul M.N., Boo, Stellar, Hinz, Boris, van Beuge, Marike M., Bank, Ruud A.·2015·The American Journal of Pathology

Abstract

Dupuytren disease is a fibrotic disorder characterized by contraction of myofibroblast-rich cords and nodules in the hands. The Hippo member Yes-associated protein 1 (YAP1) is activated by tissue stiffness and the profibrotic transforming growth factor-β1, but its role in cell fibrogenesis is yet unclear. We hypothesized that YAP1 regulates the differentiation of dermal fibroblasts into highly contractile myofibroblasts and that YAP1 governs the maintenance of a myofibroblast phenotype in primary Dupuytren cells. Knockdown of YAP1 in transforming growth factor-β1-stimulated dermal fibroblasts decreased the formation of contractile smooth muscle α-actin stress fibers and the deposition of collagen type I, which are hallmark features of myofibroblasts. Translating our findings to a clinically relevant model, we found that YAP1 deficiency in Dupuytren disease myofibroblasts resulted in decreased expression of ACTA2, COL1A1, and CCN2 mRNA, but this did not result in decreased protein levels. YAP1-deficient Dupuytren myofibroblasts showed decreased contraction of a collagen hydrogel. Finally, we showed that YAP1 levels and nuclear localization were elevated in affected Dupuytren disease tissue compared with matched control tissue and partly co-localized with smooth muscle α-actin-positive cells. In conclusion, our data show that YAP1 is a regulator of myofibroblast differentiation and contributes to the maintenance of a synthetic and contractile phenotype, in both transforming growth factor-β1-induced myofibroblast differentiation and primary Dupuytren myofibroblasts.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajpath.2015.08.011

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Ross JA, Annan JH: Dupuytren's contracture; a clinical review. Ann Surg 1952, 134:186e194
  2. Tomasek J, Rayan GM: Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts. J Hand Surg Am 1995, 20:450e455 ajp.amjpathol.org -The American Journal of Pathology
  3. Krause C, Kloen P, Ten Dijke P: Elevated transforming growth factor b and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts. Fibrogenesis Tissue Repair 2011, 4:14
  4. Van Beek JP, Kennedy L, Rockel JS, Bernier SM, Leask A: The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther 2006, 8:R36
  5. Satish L, Gallo PH, Baratz ME, Johnson S, Kathju S: Reversal of TGF- b1 stimulation of a-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts. BMC Musculoskelet Disord 2011, 12:113

Cited by

Sorted by citations

Authors
Piersma, B., de Rond, S., Werker, P. M. N., Boo, S., Hinz, B., van Beuge, M. M., & Bank, R. A.
Affiliations
  • University Medical Center Groningen (NL)
  • University of Toronto (CA)
Corresponding author
Bank, Ruud A.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2015-12
Volume
185
Issue
12
Pages
3326-3337
ISSN
0002-9440 (ISSN-L)
OpenAlex
W2174788854
Cited by
135
References
6
Citations by year
2026: 11 · 2025: 12 · 2024: 12 · 2023: 15 · 2022: 14 · 2021: 21 · 2020: 8 · 2019: 13 · 2018: 14 · 2017: 8 · 2016: 6 · 2015: 1
FWCI
8.11
Type
journal article
Language
en
Open access
Locations
  • American Journal Of Pathology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Funders
  • Netherlands Institute for Regenerative Medicine (FES0908)
  • Canadian Institutes of Health Research (210820, 286920)
Topics
  • Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
YAP, myofibroblast differentiation, Dupuytren's contracture, fibrosis, dermal fibroblasts, TGF-β1, smooth muscle actin, stress fibers, tissue stiffness, Hippo signaling pathway, connective tissue growth factor, ACTA2, COL1A1
MeSH terms
YAP-Signaling Proteins, Cell Differentiation, Cells, Cultured, Collagen, Dupuytren Contracture, Humans, Phosphoproteins, Transcription Factors, Adaptor Proteins, Signal Transducing, Transforming Growth Factor beta1, Gene Knockdown Techniques, Myofibroblasts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review